Literature DB >> 12879418

Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.

Jean-Marie Delaissé1, Thomas L Andersen, Michael T Engsig, Kim Henriksen, Tine Troen, Laurence Blavier.   

Abstract

The best established proteolytic event of osteoclasts is bone matrix solubilization by the cysteine proteinase cathepsin K. Here, however, we draw the attention on osteoclastic activities depending on matrix metalloproteinases (MMPs). We discuss the observations supporting that MMPs contribute significantly to bone matrix solubilization in specific areas of the skeleton and in some developmental and pathological situations. Our discussion takes into account (1) the characteristics of the bone remodeling persisting in the absence of cathepsin K, (2) the ultrastructure of the resorption zone in response to inactivation of MMPs and of cathepsin K in different bone types, (3) bone resorption levels in MMP knockout mice compared to wild-type mice, (4) the identification of MMPs in osteoclasts and surrounding cells, and (5) the effect of different bone pathologies on the serum concentrations of specific collagen fragments believed to discriminate between cathepsin K and MMP cleavage. Next, we provide evidence that MMPs are very critical for osteoclast migration, thereby controlling also the cell-matrix interactions required for cell attachment/detachment. The evidence supporting this role is based on a model of osteoclast recruitment in primitive long bones, an assay of osteoclast invasion through collagen gel, and the effect of proteinase inhibitors/knockouts in these models. Furthermore, we mention observations indicating a role of MMPs in initiation of bone resorption. Finally, we emphasize the many distinct ways MMPs may alter focally the extracellular environment thereby regulating the osteoclast behavior. Although the understanding of MMPs in osteoclast biology is rapidly expanding, it is suspected that important roles remain to be discovered. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879418     DOI: 10.1002/jemt.10374

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  62 in total

1.  Processing of CXCL12 by different osteoblast-secreted cathepsins.

Authors:  Nicole D Staudt; Andreas Maurer; Bärbel Spring; Hubert Kalbacher; Wilhelm K Aicher; Gerd Klein
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 2.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

3.  Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.

Authors:  W F Rodrigues; M F M Madeira; T A da Silva; J T Clemente-Napimoga; C B Miguel; V J Dias-da-Silva; O Barbosa-Neto; A H Lopes; M H Napimoga
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.

Authors:  Antonio Garcia-Gomez; Enrique M Ocio; Atanasio Pandiella; Jesús F San Miguel; Mercedes Garayoa
Journal:  Invest New Drugs       Date:  2012-07-07       Impact factor: 3.850

Review 5.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

6.  Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.

Authors:  S M Eck; P J Hoopes; B L Petrella; C I Coon; C E Brinckerhoff
Journal:  Breast Cancer Res Treat       Date:  2008-07-03       Impact factor: 4.872

7.  Growth-associated changes in the periodontal bone and molar teeth of male rats.

Authors:  María F García; Hilda Moreno; Alfredo Rigalli; Rodolfo C Puche
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

8.  Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways.

Authors:  Mayumi Iwatake; Kuniaki Okamoto; Takashi Tanaka; Takayuki Tsukuba
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

9.  Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1.

Authors:  Christoph Klenk; Stefan Schulz; Davide Calebiro; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

10.  Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.

Authors:  Anita V Neutzsky-Wulff; Mette G Sørensen; Dino Kocijancic; Diana J Leeming; Morten H Dziegiel; Morten A Karsdal; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.